Transvenous atrial defibrillation - Techniques and clinical applications

Clinical Cardiology

Volumn 22, Issue 10, 1999, Pages 614-622

  Tse, Hung Fat ^a   Lau, Chu Pak ^a   Camm, A John ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Atrial fibrillation; Transvenous atrial defibrillation

Indexed keywords

CARDIOVERSION; DEFIBRILLATION; ELECTROCARDIOGRAM; ELECTRODE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HUMAN; REVIEW; SINUS RHYTHM; TECHNIQUE; TREATMENT PLANNING;

EID: 0032835726     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960221005     Document Type: Review

References (84)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM: Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982;306:1018-1022
2. Gajewski J, Singer RB: Mortality in an insured population with atrial fibrillation. J Am Med Assoc 1981;245:1540-1544
3. Petersen P, Godtfredsen J: Atrial fibrillation: A review of course and prognosis. Acta Med Scand 1984;216:5-9
4. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB: Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998;158:229-234
5. Grogan M, Smith HC, Gersh BJ, Wood DL: Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69: 1570-1573
6. Petersen P, Madsen EB, Brun B, Pedersen F, Gyldensted C, Boysen G: Silent cerebral infarction in chronic atrial fibrillation. Stroke 1987; 18:1098-1100
7. Van Gelder IC, Crijns HJ, Blanksma PK, Landsman ML, Posma JL, Van Den Berg MP, Meijler FL, Lie KI: Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion in chronic atrial fibrillation unassociated with cardiac valve disease. J Am Coll Cardiol 1993;72:560-566
8. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumental goats. Circulation 1995;92:1954-1968
9. Zehender M, Hohnloser S, Muller B, Meinertz T, Just H: Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: Results of a comparative study and a 2-year follow-up. J Am Coll Cardiol 1992;19:1054-1059
10. Hohnloser SH, Van de Loo A, Baedeker F: Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 1995;26:852-858
11. Tieleman RG, Gosselink AT, Crijns HJ, Van Den Berg MP, De Kam PJ, Van Gilst WH, Lie KI: Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol 1997;79:53-57
12. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trial. Circulation 1990;82:1106-1116
13. Maisel WH, Kuntz KM, Reimold SC, Lee TH, Antman EM, Friedman PL, Stevenson WG: Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital. Ann Intern Med 1997;127:281-284
14. Lown B: Electrical cardioversion of cardiac arrhythmias. Br Heart J 1967;29:469-487
15. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI: Prediction of uneventful cardioversion and maintenance of sinus rhythm after direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-46
16. Yabe S, Smith WM, Daubert JP, Wolf PD, Rollins DL, Ideker RE: Conduction disturbances caused by high current density electric fields. Circ Res 1990;66:1190-1203
17. Pansegrau DU, Abboud FM: Hemodynamic effects of ventricular defibrillation. J Clin Invest 1970;49:282-297
18. Dahl CF, Ewy GA, Warner ED, Thomas ED: Myocardial necrosis from direct current counter shock: Effect of paddle size and time interval between discharge. Circulation 1974;50:956-961
19. Dunbar DN, Tobler HG, Fetter J, Gornick CC, Benson DJ, Benditt DG: Intracavity electrode catheter cardioversion of atrial tachyarrhythmias in the dog. J Am Coll Cardiol 1986;7:1015-1027
20. Kumagai K, Yamanouchi Y, Tashiro N, Hiroki T, Arakawa K: Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in dog. J Am Coll Cardiol 1990;16:497-501
21. Powell AC, Garan H, McGovern BA, Fallon JT, Krishnan SC, Ruskin JN: Low energy conversion of atrial fibrillation in the sheep. J Am Coll Cardiol 1992;20:707-711
22. Cooper RAS, Alferness CA, Smith WM, Ideker RE: Internal cardioversion of atrial fibrillation in sheep. Circulation 1993;87: 1673-1686
23. Levy S, Lacombe P, Cointe R, Bru P: High energy transcatheter cardioversion of chronic atrial fibrillation. J Am Coll Cardiol 1988;12:514-518
24. Kumagai K, Yamanouchi Y, Hiroki T, Arakawa K: Effects of transcatheter cardioversion on chronic lone atrial fibrillation. PACE 1991;14:1571-1575
25. Levy S, Lauribe P, Dolla E, Kou W, Kadish A, Calkins A, Pagannelli F, Moyal C, Bremondy M, Schork A: A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992;86:1415-1420
26. Alt E, Schmitt C, Ammer R, Coenen M, Fotuhi P, Karch M, Blasini R: Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 1994;17:1067-1078
27. Murgatroyd FD, Slade AKB, Sopher SM, Rowland E, Ward DE, Camm AJ: Efficacy and tolerability of low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995, 25:1347-1353
28. Saksena S, Prakash A, Mongeon L, Varanasi S, Kolettis T, Mathew P, De Groot P, Mehra R, Krol RB: Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol 1995;76: 913-921
29. Lok NS, Lau CP, Ho DSW, Tang YW: Hemodynamic effects and clinical determinants of defibrillation threshold for low energy transvenous atrial defibrillation in patients with chronic atrial fibrillation. PACE 1997;20:899-908
30. Levy S, Richard P, Lau CP, Lok NS, Camm AJ, Murgatroyd FD, Jordaens LJ, Kappenberger LJ, Brugada P, Ripley KL: Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997; 27:750-755
31. Levy S, Richard P, Gueunoun M, Yapo F, Trigano J, Mansouri C, Paganelli F: Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long term results. Circulation 1997;96: 253-259
32. Jain SC, Bhatnagar VM, Azami RU, Awasthey P: Elective countershock in atrial fibrillation with an intracardiac electrode: A preliminary report. J Assoc Physicians India 1970;19:821-824
33. Mirowski M, Mower MM, Langer AA: Low energy catheter cardioversion of atrial tachyarrhythmias(abstr). Clin Res 1974;22:290
34. Hartzler GO, Kallock MJ: Low energy transvenous intracavitary cardioversion of tachycardias. In Cardiac Pacing (Eds. Steinbach K, Glogar D, Laszkovics A, Scheibelhofer W, Weber H), p. 853-858. Proceedings of the VIIth World Symposium on Cardiac Pacing. Darmstadt: Steinkopff, 1983
35. Nathan AW, Bexton RS, Spurrell RAJ, Camm AJ: Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias. Br Heart J 1984;52:377-384
36. Desai PK, Mongeon L, Conlon S, Casavant D, Moon R, Pacetti P, Marchese T, Haffajee C: Is energy for transvenous defibrillation with active pectoral can feasible? (abstr). Circulation 1994;90:I-376
37. Lau CP, Lok NS: A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold. PACE 1997;20: 1-11
38. Ayers GM, Ilina M, Wagner D, Kreyenhagen P, Bernard S, Alferness C: Cardiac vein electrode locations for transvenous atrial defibrillation (abstr). J Am Coll Cardiol 1993;21:306A
39. Ayers GM, Ilina MI, Wagner DO, Sirokman WA, Griffin JC, Alfemess CA: Right atrial electrode location for transvenous atrial defibrillation (abstr). J Am Coll Cardiol 1994;23:125A
40. Lok NS, Lau CP, Tse HF, Ayers GM: Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997;1324-1330
41. Ortiz J, Niwano S, Abe H, Gonazalez X, Ayers GM, Waldo AL: Transvenous atrial defibrillation in two canine models of atrial fibrillation (abstr). J Am Coll Cardiol 1994;23:125 A
42. Hillsley RE, Yarger MD, Greenfield RA, Sorrentino RA, Wharton JM: Effect of catheter electrode length on internal atrial defibrillation thresholds in humans (abstr). Circulation 1995;92:I-473
43. Tacker WA, Schoenlein WE, Janas W, Ayers GM, Wagner DO: Catheter electrode evaluation for transvenous atrial defibrillation (abstr). PACE 1993;16:853
44. Timmermans C, Rodriguez LM, Ayers GM, Lambert H, Smeets J. Wellens HJ: Effect of electrode length on atrial defibrillation thresholds. J Cardiovasc Electrophysiol 1998;9:582-587
45. Johnson EE, Yarger MD, Wharton JM: Monophasic and biphasic waveforms for low-energy internal cardioversion of atrial fibrillation in human (abstr). Circulation 1993;88:I-592
46. Keane D, Sulke N, Cooke R, Jackson G, Sowton E: Endocardial cardioversion of atrial flutter and fibrillation (abstr). PACE 1993; 16:928
47. Keane D, Boyd E, Anderson D, Robles A, Deverall P, Morris R, Jackson G, Sowton E: Comparison of biphasic versus monophasic waveforms in epicardial atrial defibrillation. J Am Coll Cardiol 1994;24:171-176
48. Cooper RAS, Johnson EE, Wharton JM: Internal atrial defibrillation in humans: Improved efficacy of biphasic waveforms and the importance of phase duration. Circulation 1997;95:1487-1496
49. Tomassoni G, Newby KH, Kearney MM, Brandon MJ, Barold H, Natale A: Testing different biphasic waveforms and capacitances: Effect on atrial defibrillation threshold and pain perception. J Am Coll Cardiol 1996;28:695-699
50. Sra J, Bremner S, Krum D, Blanck Z, Deshpande S, Biehl M, Li H, Jazayeri MR, Akhtar M: The effect of biphasic waveforms tilt in transvenous atrial defibrillation. PACE 1997;20:1613-1618
51. Harbinson MT, Allen JD, Imam Z, Dempsey G, Anderson JM, Ayers GM, Adgey AA: Rounded biphasic waveform reduces energy requirements for transvenous catheter cardioversion of atrial fibrillation and flutter. PACE 1997;20:226-229
52. Cooper RAS, Smith WM, Ideker RE: Early activation sites after unsuccessful internal atrial defibrillation shock: The effect of electrode configuration (abstr). PACE 1996;19:706
53. Cooper RAS, Smith WM, Ideker RE: Internal cardioversion of atrial fibrillation: Marked reduction in defibrillation threshold with dual current pathways. Circulation 1997;96:2693-2700
54. Cooper RAS, Plumb VJ, Epstein AE, Kay GN, Ideker RE: Marked reduction in internal atrial defibrillation threshold with dual-current pathways and sequential shocks in human. Circulation 1998;97: 2527-2535
55. Ayers GM, Alferness CA, Ilina MB, Wagner DO, Sirokman WA, Adams JM, Griffin JC: Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation 1994;89:413-422
56. Barold HS, Wharton JM: Ventricular fibrillation resulting from synchronized internal atrial defibrillation in a patient with ventricular preexcitation. J Cardiovasc Electrophysiol 1997;8:436-440
57. Sokoloski MC, Ayers GM, Kumagai K, Khrestian CM, Niwano S, Waldo AL: Safety of transvenous atrial defibrillation: Studies in the canine sterile pericarditis model. Circulation 1997;96:1343-1350
58. Keelan ET, Krum D, Hare J, Mughal K, Li H, Akhtar M, Jazayeri MR: Safety of atrial defibrillation shocks synchronized to narrow and wide QRS complexes during atrial pacing protocols simulating atrial fibrillation in dogs. Circulation 1997;96:2022-2030
59. Schmitt C, Alt E, Plewan A, Ammer R, Leibig M, Karch M, Schomig A: Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Candiol 1996;28:994-999
60. Min X, Mongeon L, Mehra R: Analysis of CS-RA, Can-RA, Can-RV and SVC-RV systems for atrial defibrillation by using finite element human thorax model and comparisons with the clinical studies (abstr). PACE 1996;19:696
61. Gray RA, Jalife J: Effects of atrial defibrillation shocks on the ventricles in isolated sheep hearts. Circulation 1998;97:1613-1622
62. Murgatroyd FD, Johnson EE, Cooper RA, Lau CP, Alt E, Kappenburger LJ, Smith JM, Camm AJ, Wharton JM: Safety of low energy transvenous atrial defibrillation: World experience (abstr). Circulation 1994;90:14
63. Simons GR, Newby KH, Kearney MM, Brandon MJ, Natale A: Safety of transvenous low energy cardioversion of atrial fibrillation in patients with history of ventricular tachycardia: Effects of rate and repolarization time on proarrhythmic risk. PACE 1998;21: 430-437
64. Zipes DP, Jackman WM, Heger JJ, Chilson DA, Browne KF, Naccarelli GV, Rahilly GT Jr, Prystowsky EN: Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: Low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 1982;103:789-794
65. Steinhaus DM, Cardinal D, Mongeon L, Mattson L, Waters M, Foley L, Corrigan S: Atrial fibrillation: Are low energy shocks acceptable to patients? (abstr). PACE 1996;19:625
66. Ayers GM. How can atrial defibrillation be made more tolerable? In Nonpharmacological Management of Atrial Fibrillation (Eds. Murgatroyd FD, Camm AJ), p. 474-487. Armonk, NY: Future Publishing Co., 1997
67. Jung J, Heisel A, Fries R, Kollner V: Tolerability of internal low-energy shock strengths currently needed for endocardial atrial cardioversion. Am J Cardiol 1997;80:1489-1490
68. Ammer R, Alt E, Ayers G, Lehmann G, Schmitt C, Pasquantonio J, Putter K, Schmidt M, Schomig A: Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. PACE 1997;20:230-236
69. Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M: Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: A placebo-controlled study. J Am Coll Cardiol 1996;28:700-706
70. Tse HF, Lau CP, Lok NS: Early recurrence of atrial fibrillation after successful defibrillation in patients with chronic atrial fibrillation (abstr). PACE 1997;20:2305
71. Timmermans C, Rodriguez LM, Smeets JLRM, Wellens HJJ: Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 1998;9:122-128
72. Sra J, Biehl M, Blanck Z, Dhala A, Jazayeri MR, Deshpande S, Akhtar M: Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation. PACE 1998;21:1105-1110
73. Wellens H, Lau CP, Lüderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G: Atrioverter, an implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-1656
74. Lau CP, Tse HF, Ayers GM: Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. J Am Coll Cardiol 1999;33:1217-1226
75. Ortiz J, Sokoloski MC, Ayers GM, Cmolik BL, Niwano S, Geha AS, Waldo AL: Atrial defibrillation using temporary epicardial defibrillation stainless steel wire electrodes: Studies in canine sterile pericarditis model. J Am Coll Cardiol 1995;26:1356-1364
76. Alt E, Ammer R, Lehmann G, Ayers GM, Pasqantonio J, Schomig A: Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with sotalol. Am Heart J 1997;134:419-425
77. Pinski SL, Fahy GJ: The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995;92:1651-1664
78. Chung MK, Niebauer BL, Wilkoff BL, Jaeger FJ, Kidwell GA, Morant VA, Tchou PJ: Internal cardioversion of atrial fibrillation using standard ventricular implantable cardioverter-defibrillators (abstr). J Am Coll Cardiol 1998;31:38A
79. Heisel A, Jung J, Fries R, Schieffer H: Influence of active pectoral can on transvenous atrial cardioversion threshold in patients with implantable cardioverter-defibrillators (abstr). J Am Coll Cardiol 1998;31:38A
80. Lau CP, Tse HF, Lok NS, Lee KL, Ho DS, Sopher M, Murgatroyd F, Camm AJ: Initial clinical experience with an implantable human atrial defibrillator. PACE 1997;20:220-225
81. Tse HF, Lau CP, Sra JS, Crijns HJ, Edvardsson N, Kacet S, Wyse DG: Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator: Implications for long term efficacy and safety. Circulation 1999;99:1446-1451
82. Kalman JM, Olgin JE, Karch MR, Steiner PR, Stillson C, Chin MC, Lesh MD: Effect of right atrial linear lesions on atrial defibrillation threshold: Implications for 'hybrid therapy' (abstr). PACE 1996;19:625
83. Darpo B, Ayers GM, Bergfeldt L, Linde C, Johansson K, Rosenqvist M: Overdrive pacing does not lower atrial defibrillation threshold in patients with atrial fibrillation (abstr). PACE 1998;21:812
84. Delfaut P, Saksena S, Prakash A, Krol RB: Long term outcome of patients with drug refractory atrial flutter and fibrillation after single and dual site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 1998;32:1900-1908